Zheng X L, Renaux B, Hollenberg M D
Endocrine Research Group, Department of Pharmacology & Therapeutics, The University of Calgary Faculty of Medicine, Calgary, Alberta, Canada T2N 4N1.
J Pharmacol Exp Ther. 1998 Apr;285(1):325-34.
Using a guinea pig gastric longitudinal smooth muscle preparation, we have compared the contractile signaling pathways triggered by the thrombin receptor-activating peptide, TFLLR-NH2 (TF) and by epidermal growth factor-urogastrone (EGF). In addition to inhibitors of tyrosine kinase [tyrphostin 47/AG213, genistein and the src-selective inhibitor CP118,556/PP1], cyclooxygenase (indomethacin, INDO) and diacylglycerol lipase (U57, 908), we also used the signal pathway probe inhibitors of mitogen-activated protein-kinase-kinase (MEK:PD98059), phosphatidylinositol 3'-kinase [PI3K: Wortmannin (WM) and LY294002], protein kinase C [PKC: GF109203X (GF)], and of the EGF-receptor kinase (PD153035). We found that in addition to the inhibition of both TF and EGF-stimulated contractions by the inhibitors of tyrosine kinase, cyclooxygenase and diacylglycerol lipase, the actions of TF and EGF were also attenuated by PD98059, WM/LY294002 and GF. However, PD153035 blocked only EGF-triggered contractions. The contractile actions of both TF and EGF were dependent on extracellular calcium. In contrast, the contractile action of arachidonic acid, via a presumed cyclooxygenase product that mediated the contractions caused by both TF and EGF, was not blocked by any of the signal pathway probe inhibitors. The contractile actions of both TF and EGF were accompanied by increases in tissue phosphotyrosyl proteins and an increase in tissue c-src kinase activity. We conclude that protease-activated receptor no. 1- (thrombin receptor) mediated contractions in the logitudial muscle, like EGF receptor-activated responses, require the influx of extracellular calcium and use parallel signal pathways upstream of the cyclooxygenase step, involving MEK, PI3K, kinase C and possibly cellular src. The TF-induced response did not involve trans-activation of the EGF receptor kinase; but the converse (i.e., trans-activation of protease-activated receptor no. 1 (thrombin receptor) by the EGF receptor kinase) could not be ruled out.
利用豚鼠胃纵行平滑肌制备物,我们比较了凝血酶受体激活肽TFLLR-NH2(TF)和表皮生长因子-尿抑胃素(EGF)触发的收缩信号通路。除了酪氨酸激酶抑制剂[ tyrphostin 47/AG213、染料木黄酮和src选择性抑制剂CP118,556/PP1]、环氧化酶(吲哚美辛,INDO)和二酰基甘油脂肪酶(U57,908)外,我们还使用了丝裂原活化蛋白激酶激酶(MEK:PD98059)、磷脂酰肌醇3'-激酶[PI3K:渥曼青霉素(WM)和LY294002]、蛋白激酶C[PKC:GF109203X(GF)]以及EGF受体激酶(PD153035)的信号通路探针抑制剂。我们发现,除了酪氨酸激酶、环氧化酶和二酰基甘油脂肪酶抑制剂抑制TF和EGF刺激的收缩外,PD98059、WM/LY294002和GF也减弱了TF和EGF的作用。然而,PD153035仅阻断EGF触发的收缩。TF和EGF的收缩作用均依赖于细胞外钙。相反,花生四烯酸的收缩作用,通过一种推测的环氧化酶产物介导了TF和EGF引起的收缩,未被任何信号通路探针抑制剂阻断。TF和EGF的收缩作用均伴随着组织磷酸酪氨酸蛋白的增加和组织c-src激酶活性的增加。我们得出结论,蛋白酶激活受体1-(凝血酶受体)介导的纵行肌收缩,与EGF受体激活的反应一样,需要细胞外钙的内流,并在环氧化酶步骤上游使用平行的信号通路,涉及MEK、PI3K、激酶C以及可能的细胞src。TF诱导的反应不涉及EGF受体激酶的反式激活;但相反情况(即EGF受体激酶对蛋白酶激活受体1(凝血酶受体)的反式激活)不能排除。